已收盘 09-28 16:00:00 美东时间
0.000
0.00%
Pyxis Oncology appoints Nelson Azoulay as Chief Business Officer. With over 15 years of experience in corporate strategy and biopharma transactions, Azoulay will lead corporate development and advance MICVO, the company's lead ADC targeting EDB+FN in solid tumors. MICVO is in Phase 1/2 trials for recurrent/metastatic head and neck cancer and has received FDA Fast Track Designation. Azoulay's expertise in ADCs and strategic transactions is expecte...
05-07 20:05
<p>Telix Pharmaceuticals Limited has appointed David Gill as a Non-Executive Director, effective May 11, 2026, with plans for him to become Chair in the future. Mr. Gill, a seasoned executive with over 35 years of experience in finance and leadership roles, brings expertise in capital markets, business scaling, and corporate strategy. Telix, a global biopharmaceutical company focused on radiopharmaceuticals, aims to strengthen its board as it con...
04-01 23:53
Syneos Health (($SYNH)) announced an update on their ongoing clinical study. St...
2025-08-15 00:21
By Svea Herbst-Bayliss BEVERLY HILLS, May 7 (Reuters) - Pharmaceutical company Charles River Laboratories CRL.N has reached a settlement with activist investor Elliott Investment Management to add fou...
2025-05-07 18:00
CytoDyn (OTCQB:CYDY) said the FDA has cleared a Phase 2 study of its drug leronlimab for the treatment of relapsed/refractory microsatellite stable colorectal cancer. Patient enrollment for the study ...
2024-11-04 23:22
NEW YORK, May 10, 2023 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or ...
2023-05-11 00:17
美股股指期货周三盘前涨跌互现,美国消费者物价指数将于今日公布,可能影响今年降息的预期。与此同时,美国总统拜登未能在债务上限问题上打破僵局,亦打压市场。 ...
2023-05-10 20:26
Syneos Health (NASDAQ:SYNH) reported its Q1 earnings results on Wednesday, May ...
2023-05-10 19:15
格隆汇5月10日丨由Elliott带领的财团将以每股43美元的价格收购Syneos Health,收购预计于今年下半年完成。
2023-05-10 19:06